{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:24:56Z","timestamp":1787181896857,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014733","name":"Middle East University","doi-asserted-by":"publisher","award":["2025\/2024-869"],"award-info":[{"award-number":["2025\/2024-869"]}],"id":[{"id":"10.13039\/501100014733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005712","name":"University of Jordan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005712","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.biopha.2026.119794","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:27:44Z","timestamp":1784755664000},"page":"119794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cabazitaxel and camptothecin co-loaded in pH-sensitive transferrin-targeted, PEGylated cholesterol-based poly(amidoamine) dendrimers as a synergistic combination for prostate cancer"],"prefix":"10.1016","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9411-4912","authenticated-orcid":false,"given":"Musa","family":"Albatsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8134-079X","authenticated-orcid":false,"given":"Yousef","family":"Ijjeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2236-8938","authenticated-orcid":false,"given":"Nowar","family":"Alsarayreh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6127-2259","authenticated-orcid":false,"given":"Dana A.","family":"Alqudah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2946-7328","authenticated-orcid":false,"given":"Walhan","family":"Alshaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119794_bib1","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.biopha.2026.119794_bib2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/pros.70082","article-title":"Efficacy of early switching from docetaxel to cabazitaxel in castration-resistant prostate cancer","author":"Kawai","year":"2026","journal-title":"Prostate"},{"key":"10.1016\/j.biopha.2026.119794_bib3","article-title":"Cabazitaxel vs docetaxel in chemotherapy-na\u00efve patients with metastatic castration-resistant prostate cancer: a three-arm phase III study (FIRSTANA)","volume":"15","author":"Sartor","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2026.119794_bib4","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.3390\/ijms26125903","article-title":"Exploring carboxamide derivatives as promising anti-cancer agents: design, in vitro evaluation, and mechanistic insights","volume":"26","author":"Al-Najdawi","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119794_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71507","article-title":"Heterogeneity in treatment effects of reduced versus standard dose of cabazitaxel in metastatic castration-resistant prostate cancer","volume":"15","author":"Fukuokaya","year":"2026","journal-title":"Cancer Med."},{"key":"10.1016\/j.biopha.2026.119794_bib6","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1111\/cas.13729","article-title":"Analysis of cabazitaxel-resistant mechanism in human castration-resistant prostate cancer","volume":"109","author":"Hongo","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2026.119794_bib7","first-page":"1","article-title":"G-protein signaling of oxytocin receptor as a potential target for cabazitaxel-resistant prostate cancer","volume":"3","author":"Hongo","year":"2024","journal-title":"PNAS Nexus"},{"issue":"1","key":"10.1016\/j.biopha.2026.119794_bib8","first-page":"1","article-title":"Characterization of camptothecin by analytical methods and determination of anti-cancer potential against prostate cancer","author":"Galatage","year":"2021","journal-title":"Future J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2026.119794_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.130085","article-title":"Design, synthesis and biological evaluation of camptothecin analogue FL118 as a payload for antibody-drug conjugates in targeted cancer therapy","volume":"118","author":"Mathi","year":"2025","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2026.119794_bib10","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3390\/pharmaceutics17111414","article-title":"Camptothecin in cancer therapy: current challenges and emerging strategies with nanoemulsions","volume":"17","author":"P\u00e9rez-Ortega","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119794_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12032-024-02527-x","article-title":"Camptothecin and its derivatives: advancements, mechanisms and clinical potential in cancer therapy","volume":"41","author":"Kamle","year":"2024","journal-title":"Med. Oncol."},{"key":"10.1016\/j.biopha.2026.119794_bib12","doi-asserted-by":"crossref","first-page":"22830","DOI":"10.1039\/C8NR08141G","article-title":"Redox-sensitive, cholesterol-bearing PEGylated poly(propylene imine)-based dendrimersomes for drug and gene delivery to cancer cells","volume":"10","author":"Laskar","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2026.119794_bib13","doi-asserted-by":"crossref","first-page":"125806","DOI":"10.1016\/j.colsurfa.2020.125806","article-title":"Transferrin-functionalized liposomes for docetaxel delivery to prostate cancer cells","volume":"611","author":"Fernandes","year":"2021","journal-title":"Colloids Surf. A"},{"key":"10.1016\/j.biopha.2026.119794_bib14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou\u2013Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119794_bib15","series-title":"Bioconjugate Techniques","first-page":"549","author":"Hermanson","year":"2013"},{"key":"10.1016\/j.biopha.2026.119794_bib16","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/cyto.a.23863","article-title":"Evaluation of deep learning strategies for nucleus segmentation in fluorescence images","volume":"95","author":"Caicedo","year":"2019","journal-title":"Cytom. Part. A"},{"key":"10.1016\/j.biopha.2026.119794_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1099800403256860","article-title":"Endocytosis and signal transduction: basic science update","volume":"5","author":"Liu","year":"2003","journal-title":"Biol. Res. Nurs."},{"key":"10.1016\/j.biopha.2026.119794_bib18","doi-asserted-by":"crossref","first-page":"1572212","DOI":"10.3389\/fcell.2025.1572212","article-title":"Evaluation of image analysis tools for the measurement of cellular morphology","volume":"13","author":"Bourn","year":"2025","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.biopha.2026.119794_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000519861","article-title":"Metastatic prostate cancer: treatment options","volume":"100","author":"Achard","year":"2022","journal-title":"Oncology"},{"key":"10.1016\/j.biopha.2026.119794_bib20","first-page":"1681","article-title":"Genistein enhances the efficacy of cabazitaxel chemotherapy in metastatic castration-resistant prostate cancer cells","author":"Zhang","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.biopha.2026.119794_bib21","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1007\/s11033-022-07343-y","article-title":"The synergistic anti-cancer effect of salinomycin combined with cabazitaxel in CD44+ prostate cancer cells by downregulating Wnt, NF-\u03baB and AKT signaling","volume":"49","author":"Erdogan","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.biopha.2026.119794_bib22","first-page":"97","article-title":"Synergistic combination of microtubule targeting anti-cancer fludelone with cytoprotective panaxytriol derived from Panax ginseng against MX-1 cells in vitro: experimental design and data analysis using the combination index method","volume":"6","author":"Zhang","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119794_bib23","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2174\/0118715206336754241015062614","article-title":"Synergistic anti-tumorigenic effects of cabazitaxel and usnic acid combination on metastatic castration-resistant prostate cancer cells","volume":"25","author":"Bergel","year":"2025","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"10.1016\/j.biopha.2026.119794_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-27400-6","article-title":"PEGylation of polypropylenimine dendrimers: effects on cytotoxicity, DNA condensation, gene delivery and expression in cancer cells","volume":"8","author":"Somani","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119794_bib25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcis.2014.05.068","article-title":"vitro evaluation of pH-sensitive cholesterol-containing stable polymeric micelles for delivery of camptothecin","volume":"430","author":"Laskar","year":"2014","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.biopha.2026.119794_bib26","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.addr.2009.03.014","article-title":"Transcriptionally regulated, prostate-targeted gene therapy for prostate cancer","volume":"61","author":"Lu","year":"2009","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119794_bib27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2217\/nnm.13.25","article-title":"Therapeutic efficacy of intravenously administered transferrin-conjugated dendriplexes on prostate carcinomas","volume":"9","author":"Al Robaian","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2026.119794_bib28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jiec.2022.07.026","article-title":"Dendrimeric micelles composed of polyamidoamine dendrimer-peptide-cholesterol conjugates as drug carriers for the treatment of melanoma and bacterial infection","volume":"114","author":"Thuy","year":"2022","journal-title":"J. Ind. Eng. Chem."},{"key":"10.1016\/j.biopha.2026.119794_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2018.11.009","article-title":"Cabazitaxel and thymoquinone co-loaded lipospheres as a synergistic combination for breast cancer","volume":"224","author":"Kommineni","year":"2019","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.biopha.2026.119794_bib30","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1080\/03639045.2025.2552392","article-title":"Use of nanoemulsion for co-delivery of silibinin and cabazitaxel for prostate cancer treatment","volume":"51","author":"Almutairy","year":"2025","journal-title":"Drug. Dev. Ind. Pharm."},{"key":"10.1016\/j.biopha.2026.119794_bib31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/CAD.0000000000000464","article-title":"Potential anti-cancer role of colchicine-based derivatives: an overview","volume":"28","author":"Kumar","year":"2017","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.biopha.2026.119794_bib32","doi-asserted-by":"crossref","first-page":"188481","DOI":"10.1016\/j.bbcan.2020.188481","article-title":"Mechanisms of docetaxel resistance in prostate cancer: the key role played by miRNAs","volume":"1876","author":"Rizzo","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.biopha.2026.119794_bib33","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.7150\/thno.9933","article-title":"Enhancing therapeutic effects of docetaxel-loaded dendritic copolymer nanoparticles by co-treatment with autophagy inhibitor on breast cancer","volume":"4","author":"Zhang","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2026.119794_bib34","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.7150\/thno.14858","article-title":"The smart drug delivery system and its clinical potential","volume":"6","author":"Liu","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2026.119794_bib35","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s11095-010-0179-6","article-title":"PAMAM-camptothecin conjugate inhibits proliferation and induces nuclear fragmentation in colorectal carcinoma cells","volume":"27","author":"Thiagarajan","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2026.119794_bib36","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1038\/s41598-018-23847-9","article-title":"Discrimination between the human prostate normal and cancer cell exometabolome by GC-MS","volume":"8","author":"Lima","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119794_bib37","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3390\/life12101607","article-title":"Preclinical and clinical research models of prostate cancer: a brief overview","volume":"12","author":"Basak","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.biopha.2026.119794_bib38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","article-title":"Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology","volume":"66","author":"Bertrand","year":"2014","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119794_bib39","first-page":"916","article-title":"Transferrin receptor 1 in cancer: a new sight for cancer therapy","volume":"6","author":"Shen","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119794_bib40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.clim.2006.06.006","article-title":"The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells","volume":"121","author":"Daniels","year":"2006","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.biopha.2026.119794_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095058","article-title":"The aryl hydrocarbon receptor is constitutively active in advanced prostate cancer cells","volume":"9","author":"Richmond","year":"2014","journal-title":"PLoS. One"},{"key":"10.1016\/j.biopha.2026.119794_bib42","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3389\/fphar.2019.01436","article-title":"Docetaxel and doxorubicin codelivery by nanocarriers for synergistic treatment of prostate cancer","volume":"10","author":"Li","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119794_bib43","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.colsurfb.2014.10.024","article-title":"Transferrin conjugated poly(\u03b3-glutamic acid-maleimide-co-L-lactide)-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine copolymer nanoparticles for targeting drug delivery","volume":"123","author":"Zhao","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biopha.2026.119794_bib44","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ijbiomac.2018.06.114","article-title":"Cholesterol-grafted chitosan micelles as a nanocarrier system for drug-siRNA co-delivery to lung cancer cells","volume":"118","author":"Muddineti","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2026.119794_bib45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/HM9.0000000000000096","article-title":"A novel cabazitaxel liposomes modified with ginsenoside Rk1 for cancer targeted therapy","volume":"4","author":"Huang","year":"2024","journal-title":"Acupunct. Herb. Med."},{"key":"10.1016\/j.biopha.2026.119794_bib46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.apmt.2018.05.002","article-title":"PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy","volume":"12","author":"Abedi-Gaballu","year":"2018","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.biopha.2026.119794_bib47","doi-asserted-by":"crossref","first-page":"7782","DOI":"10.1039\/D3OB01265D","article-title":"Cell internalization kinetics and surface charge accessibility of surface-modified PAMAM dendrimers","volume":"21","author":"D\u00edaz","year":"2023","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.biopha.2026.119794_bib48","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1046\/j.1464-410x.2000.00606.x","article-title":"Phenotypic and genotypic characterization of commonly used human prostatic cell lines","volume":"85","author":"Mitchell","year":"2000","journal-title":"BJU Int."},{"key":"10.1016\/j.biopha.2026.119794_bib49","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00018-007-6390-x","article-title":"Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells","volume":"64","author":"Kim","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2026.119794_bib50","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-981-97-7316-9_6","article-title":"PEGylation as a tool to alter immunological properties of nanocarriers","author":"Tiwari","year":"2025","journal-title":"PEGylated Nanocarriers Med. Pharm."},{"key":"10.1016\/j.biopha.2026.119794_bib51","first-page":"559","article-title":"Cytotoxic and antimicrobial analysis of biosynthesized selenium nanoparticles from Solanum tuberosum peels","volume":"9","author":"Aktepe","year":"2025","journal-title":"Int. J. Agric. Environ. Food Sci."},{"key":"10.1016\/j.biopha.2026.119794_bib52","first-page":"495","article-title":"Studying the antimicrobial effects of silver nanoparticles (AgNPs) derived from the agricultural byproduct of Rhus coriaria L. (sumac)","volume":"10","author":"Baran","year":"2026","journal-title":"ISPEC J. Agric. Sci."},{"key":"10.1016\/j.biopha.2026.119794_bib53","first-page":"206","article-title":"Evaluation of in vivo wound healing activity of Pistacia vera L. hull extract on excision wound model in rats","volume":"11","author":"Polat","year":"2026","journal-title":"MAS J. Appl. Sci."},{"key":"10.1016\/j.biopha.2026.119794_bib54","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/10611860410001701706","article-title":"Validation of the transferrin receptor for drug targeting to brain capillary endothelial cells in vitro","volume":"12","author":"Visser","year":"2004","journal-title":"J. Drug. Target."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T22:49:19Z","timestamp":1787179759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226008309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":54,"alternative-id":["S0753332226008309"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119794","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cabazitaxel and camptothecin co-loaded in pH-sensitive transferrin-targeted, PEGylated cholesterol-based poly(amidoamine) dendrimers as a synergistic combination for prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119794","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119794"}}